🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Rosiglitazone (RSG) has been tested in clinical studies and is approved by ...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-07-06
Trial ID
NCT00348309
Treatments Being Tested
The purpose of this phase III study is to further evaluate the effects of s...
Status
Completed
Location
Dongzhimen Hospital,BUCM
Start Date
2008-09
Trial ID
NCT01451749
Treatments Being Tested
The purpose of this study is to determine the safety of intravenous cocaine...
Status
Completed
Location
VA Medical Center
Start Date
2007-02
Trial ID
NCT00467389
Treatments Being Tested
Primary Objective: \- To demonstrate the efficacy of at least one dose of ...
Status
Completed
Location
Investigational Site Number 840041
Start Date
2011-02
Trial ID
NCT01266525
Treatments Being Tested
This study is being conducted to determine the safety, tolerability, and ph...
Status
Completed
Location
Pacific Research Network, Inc.
Start Date
2008-10
Trial ID
NCT00766363
A study to assess the skin irritation and sensitization potential of Corple...
Status
Completed
Location
Celerion Inc.
Start Date
2017-11-14
Trial ID
NCT03397862
Treatments Being Tested
This study is to compare the safety and effects of donepezil (Aricept) for ...
Status
Completed
Location
Kaiser Permanente-Anaheim
Start Date
2017-05-30
Trial ID
NCT02822573
Treatments Being Tested
This study is designed to assess skin tolerability, skin irritation, and ad...
Status
Completed
Location
Xenoscience, Inc
Start Date
2009-05
Trial ID
NCT00916383
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of Aricept ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2002-10
Trial ID
NCT00630851
Treatments Being Tested
This study will compare the effects of gabapentin alone, and gabapentin + d...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-10-11
Trial ID
NCT01485185
Treatments Being Tested